124 related articles for article (PubMed ID: 34270886)
1. Histone demethylase KDM5A enhances cell proliferation, induces EMT in lung adenocarcinoma cells, and have a strong causal association with paclitaxel resistance.
Xu L; Wu H; Hu X
Acta Biochim Pol; 2021 Jul; 68(4):593-602. PubMed ID: 34270886
[TBL] [Abstract][Full Text] [Related]
2. KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance.
Feng T; Wang Y; Lang Y; Zhang Y
Mol Med Rep; 2017 Sep; 16(3):3573-3580. PubMed ID: 28714030
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel.
Huang Z; Gao Y; Hou D
Hum Cell; 2020 Jul; 33(3):850-858. PubMed ID: 32452013
[TBL] [Abstract][Full Text] [Related]
4. A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition.
Zhao YF; Han ML; Xiong YJ; Wang L; Fei Y; Shen X; Zhu Y; Liang ZQ
Acta Pharmacol Sin; 2018 Jun; 39(6):1034-1047. PubMed ID: 29219949
[TBL] [Abstract][Full Text] [Related]
5. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth.
Yang X; Zhao D; Li Y; Li Y; Cui W; Li Y; Li H; Li X; Wang D
Thorac Cancer; 2020 Oct; 11(10):2858-2866. PubMed ID: 32875729
[TBL] [Abstract][Full Text] [Related]
6.
Pu J; Shen J; Zhong Z; Yanling M; Gao J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):639-647. PubMed ID: 32064933
[TBL] [Abstract][Full Text] [Related]
7. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
Ko H
Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.
Han ML; Zhao YF; Tan CH; Xiong YJ; Wang WJ; Wu F; Fei Y; Wang L; Liang ZQ
Acta Pharmacol Sin; 2016 Dec; 37(12):1606-1622. PubMed ID: 27840408
[TBL] [Abstract][Full Text] [Related]
9. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities.
Ashrafizadeh M; Mirzaei S; Hashemi F; Zarrabi A; Zabolian A; Saleki H; Sharifzadeh SO; Soleymani L; Daneshi S; Hushmandi K; Khan H; Kumar AP; Aref AR; Samarghandian S
Biomed Pharmacother; 2021 Sep; 141():111824. PubMed ID: 34175815
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma.
Ren K; Xu R; Huang J; Zhao J; Shi W
Cancer Chemother Pharmacol; 2017 Aug; 80(2):243-250. PubMed ID: 28600629
[TBL] [Abstract][Full Text] [Related]
11. Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells.
Tian X; Zhang H; Zhang B; Zhao J; Li T; Zhao Y
Oncol Rep; 2017 Jul; 38(1):293-300. PubMed ID: 28586074
[TBL] [Abstract][Full Text] [Related]
12. [SP13786 Inhibits the Migration and Invasion of Lung Adenocarcinoma Cell A549
by Supressing Stat3-EMT via CAFs Exosomes].
Wang S; Cui J; Zhang K; Gu J; Zheng Y; Zhang B; Shi L
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):384-393. PubMed ID: 34024061
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells.
Du F; Wu X; Liu Y; Wang T; Qi X; Mao Y; Jiang L; Zhu Y; Chen Y; Zhu R; Han X; Jin J; Ma X; Hua D
Oncol Rep; 2013 Sep; 30(3):1113-8. PubMed ID: 23807572
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol.
Sun QL; Sha HF; Yang XH; Bao GL; Lu J; Xie YY
J Cancer Res Clin Oncol; 2011 Mar; 137(3):521-32. PubMed ID: 20499251
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells.
Kim EH; Min HY; Chung HJ; Song J; Park HJ; Kim S; Lee SK
Food Chem Toxicol; 2012 Mar; 50(3-4):1060-5. PubMed ID: 22120505
[TBL] [Abstract][Full Text] [Related]
16. KDM5A regulates the growth and gefitinib drug resistance against human lung adenocarcinoma cells.
Wu H; Xu L; Hu X
3 Biotech; 2022 Apr; 12(4):97. PubMed ID: 35371900
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells.
Li H; Zhang P; Sun X; Sun Y; Shi C; Liu H; Liu X
Int J Oncol; 2015 Oct; 47(4):1379-92. PubMed ID: 26323677
[TBL] [Abstract][Full Text] [Related]
18. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
[TBL] [Abstract][Full Text] [Related]
19. Xanthohumol Impairs the PMA-Driven Invasive Behaviour of Lung Cancer Cell Line A549 and Exerts Anti-EMT Action.
Sławińska-Brych A; Mizerska-Kowalska M; Król SK; Stepulak A; Zdzisińska B
Cells; 2021 Jun; 10(6):. PubMed ID: 34204745
[TBL] [Abstract][Full Text] [Related]
20. Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis.
Xue YN; Yu BB; Liu YN; Guo R; Li JL; Zhang LC; Su J; Sun LK; Li Y
Prostate; 2019 May; 79(6):647-656. PubMed ID: 30714183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]